A parkinson-kór genetikája és aktuális terápiás lehetocombining double acute accentségei

B. Bereznai, Mária Judit Molnár

Research output: Article

3 Citations (Scopus)

Abstract

In the past years, six monogenic forms of Parkinson disease have clearly been associated with this movement disorder. The most frequent forms are LRRK2- and Parkin-associated Parkinson disease. Currently, a genetic diagnosis does not change the therapy, the genes involved in genetic Parkinson disease help to understand the underlying pathophysiologic mechanisms of Parkinson disease. Beside the overview of the molecular-genetic basis, we give a review about genetic testing, pharmacological and other multidisciplinary treatment options.

Original languageHungarian
Pages (from-to)155-163
Number of pages9
JournalIdeggyógyászati szemle
Volume62
Issue number5-6
Publication statusPublished - máj. 30 2009

Fingerprint

Genetic Therapy
Parkinson Disease
Inborn Genetic Diseases
Movement Disorders
Genetic Testing
Molecular Biology
Pharmacology
Therapeutics

Keywords

  • Deep brain stimulation
  • Gen test
  • Genetics
  • Multidisciplinary therapy
  • Parkinson disease
  • Slow release dopamin agonist

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

A parkinson-kór genetikája és aktuális terápiás lehetocombining double acute accentségei. / Bereznai, B.; Molnár, Mária Judit.

In: Ideggyógyászati szemle, Vol. 62, No. 5-6, 30.05.2009, p. 155-163.

Research output: Article

@article{5b838ed4ff6e4a61bd7b3c74cac6ddee,
title = "A parkinson-k{\'o}r genetik{\'a}ja {\'e}s aktu{\'a}lis ter{\'a}pi{\'a}s lehetocombining double acute accents{\'e}gei",
abstract = "In the past years, six monogenic forms of Parkinson disease have clearly been associated with this movement disorder. The most frequent forms are LRRK2- and Parkin-associated Parkinson disease. Currently, a genetic diagnosis does not change the therapy, the genes involved in genetic Parkinson disease help to understand the underlying pathophysiologic mechanisms of Parkinson disease. Beside the overview of the molecular-genetic basis, we give a review about genetic testing, pharmacological and other multidisciplinary treatment options.",
keywords = "Deep brain stimulation, Gen test, Genetics, Multidisciplinary therapy, Parkinson disease, Slow release dopamin agonist",
author = "B. Bereznai and Moln{\'a}r, {M{\'a}ria Judit}",
year = "2009",
month = "5",
day = "30",
language = "Hungarian",
volume = "62",
pages = "155--163",
journal = "Ideggyogyaszati Szemle",
issn = "0019-1442",
publisher = "Ifjusagi Lap-es Konyvkiado Vallalat",
number = "5-6",

}

TY - JOUR

T1 - A parkinson-kór genetikája és aktuális terápiás lehetocombining double acute accentségei

AU - Bereznai, B.

AU - Molnár, Mária Judit

PY - 2009/5/30

Y1 - 2009/5/30

N2 - In the past years, six monogenic forms of Parkinson disease have clearly been associated with this movement disorder. The most frequent forms are LRRK2- and Parkin-associated Parkinson disease. Currently, a genetic diagnosis does not change the therapy, the genes involved in genetic Parkinson disease help to understand the underlying pathophysiologic mechanisms of Parkinson disease. Beside the overview of the molecular-genetic basis, we give a review about genetic testing, pharmacological and other multidisciplinary treatment options.

AB - In the past years, six monogenic forms of Parkinson disease have clearly been associated with this movement disorder. The most frequent forms are LRRK2- and Parkin-associated Parkinson disease. Currently, a genetic diagnosis does not change the therapy, the genes involved in genetic Parkinson disease help to understand the underlying pathophysiologic mechanisms of Parkinson disease. Beside the overview of the molecular-genetic basis, we give a review about genetic testing, pharmacological and other multidisciplinary treatment options.

KW - Deep brain stimulation

KW - Gen test

KW - Genetics

KW - Multidisciplinary therapy

KW - Parkinson disease

KW - Slow release dopamin agonist

UR - http://www.scopus.com/inward/record.url?scp=67651064960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651064960&partnerID=8YFLogxK

M3 - Article

C2 - 19579663

AN - SCOPUS:67651064960

VL - 62

SP - 155

EP - 163

JO - Ideggyogyaszati Szemle

JF - Ideggyogyaszati Szemle

SN - 0019-1442

IS - 5-6

ER -